Simplify High Yield ETF
Limited financial coverage for CDX.
Not enough data to compute a meaningful composite — typical for foreign-listed ADRs, recent IPOs, or thinly-covered small caps. Live quote, chart, and any available stats still render below.
Price Chart
About the company
The Simplify High Yield ETF (CDX) is engineered to generate substantial current income. It achieves this by primarily allocating its capital to high-yield bonds, while simultaneously deploying strategies to reduce inherent credit risk. CDX offers foundational exposure to the high-yield market, delivering appealing income streams, and is fortified by a diverse array of dynamic and effective credit hedging techniques.
- IPO
- 2022
- HQ
- Las Vegas, NV, US
Get TickerSpark's AI analysis on CDX
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Similar companies
Peers in the same neighborhood.
- Market Cap
- $393.71M
- Div Yield
- 8.31%
- 52W High
- $23.11
- 52W Low
- $20.42
- 50D MA
- $20.92
- 200D MA
- $21.68
- Beta
- 0.56
- RSI (14)
- 44
- Avg Volume
- 151.12K
No earnings-call transcripts are available for CDX yet.
- Free Float
- 0.0%
- Shares Outstanding
- 19.01M
- Float Shares
- 0
of shares held by institutions
85 13F filers
Top institutional holders
Largest 13F positions, with quarter-over-quarter change.
| Holder | Shares | Δ Quarter |
|---|---|---|
| Kingsview Wealth Management, LLC | 124.70K | ▲ 17.66K |
| Avantax Advisory Services, Inc. | 42.76K | ▲ 858 |
| Napa Wealth Management | 22.42K | ▲ 473 |
| Cove Street Capital, LLC | 16.58K | ▲ 16.58K |
| Cwm, LLC | 9.11K | ▲ 3.70K |
Held by 1 ETFs
Biggest fund positions in CDX by dollar value.
Recent insider transactions
Who's buying, who's selling, and how much.
| Date | Insider | Type | Shares |
|---|---|---|---|
| Sep 15, 05 | ANTENUCCI TED R | sell | 371,148 |
| Sep 15, 05 | BARKER PETER K | sell | 1,872 |
| Sep 15, 05 | BOLLENBACH STEPHEN F | sell | 5,855 |
| Sep 15, 05 | BOLLENBACH STEPHEN F | sell | 5,855 |
| Sep 15, 05 | BOLLENBACH STEPHEN F | sell | 27,667 |
| Sep 15, 05 | BOLLENBACH STEPHEN F | sell | 5,855 |
| Sep 15, 05 | BOLLENBACH STEPHEN F | sell | 5,855 |
| Sep 15, 05 | BOLLENBACH STEPHEN F | sell | 5,855 |
| Sep 15, 05 | CARTER DARYL J | sell | 4,391 |
| Sep 15, 05 | CARTER DARYL J | sell | 32,259 |
A “Sell” may be a pre-scheduled 10b5-1 plan sale rather than a discretionary decision — read insider selling with that in mind.
Our CDX coverage
Recent articles, reports, and earnings notes.
No research on CDX yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate CDX report →CDX: The Active High Yield Management Working In The Opposite Direction
seekingalpha.com · Jul 27
Celldex Presents Positive First-in-Human Results from Phase 1 Study of Novel Bispecific CDX-622 at the European Academy of Allergy and Clinical Immunology Annual Meeting
globenewswire.com · Jun 14
Simplify High Yield ETF (NYSEARCA:CDX) Short Interest Up 1,869.9% in March
defenseworld.net · Mar 25
Simplify High Yield ETF $CDX Shares Purchased by AE Wealth Management LLC
defenseworld.net · Jan 30
Simplify Provides Estimated Capital Gain Distribution Information for 2025
businesswire.com · Dec 12
Navigating Private Credit: Simplify's Christopher Getter on PCR
etftrends.com · Dec 1
CDX: A High-Yield Fund Built For The Crunch
seekingalpha.com · Nov 24
Headlines from third-party outlets — TickerSpark isn't affiliated with these sources.